Cardiogenic shock (CS) is a complex multifactorial clinical syndrome with extremely high
mortality, developing as a continuum, and progressing from the initial insult (underlying …

Acute decompensated heart failure (ADHF) is one of the leading admission diagnoses
worldwide, yet it is an entity with incompletely understood pathophysiology and limited …

Background Cardiogenic shock is associated with substantial morbidity and mortality.
Although inotropic support is a mainstay of medical therapy for cardiogenic shock, little …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Background Extracorporeal membrane oxygenation (ECMO) is a form of life support that
targets the heart and lungs. Extracorporeal membrane oxygenation for severe respiratory …

BACKGROUND Venoarterial extracorporeal membrane oxygenation (VA ECMO) is
associated with variable outcomes. In this meta-analysis, we evaluated the mortality after VA …

Cardiogenic shock in the setting of acute myocardial infarction remains a major cause of
morbidity and mortality. In fact, acute myocardial infarction accounts for 81% of patients in …

Introduction: The clinical impact of invasive hemodynamic support with Impella in patients
with cardiogenic shock (CS) remains to be defined. Methods: Only studies including patients …

Preclinical large animal models of heart failure (HF) play a critical and expanding role in
translating basic science findings to the development and clinical approval of novel …

We report the first US experience of the recently approved micro-axial surgical heart pump
for the treatment of ongoing cardiogenic shock following acute myocardial infarction …